Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'fMet-Leu-Phe receptor' and Ligand = 'BDBM497402'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM497402 (US11008301, Example 50) Show SMILES Fc1cc(ccc1N1CCC[C@@H](NC(=O)Nc2ccc(nc2)C(F)(F)F)C1=O)N1CCCCC1=O |r| Show InChI InChI=1S/C23H23F4N5O3/c24-16-12-15(31-10-2-1-5-20(31)33)7-8-18(16)32-11-3-4-17(21(32)34)30-22(35)29-14-6-9-19(28-13-14)23(25,26)27/h6-9,12-13,17H,1-5,10-11H2,(H2,29,30,35)/t17-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US11008301 (2021) BindingDB Entry DOI: 10.7270/Q2HX1GTH
					More data for this Ligand-Target Pair